Filing Details

Accession Number:
0001144204-16-076474
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-01-21 14:44:20
Reporting Period:
2016-01-19
Filing Date:
2016-01-21
Accepted Time:
2016-01-21 14:44:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
895051 Casi Pharmaceuticals Inc. CASI Biological Products, (No Disgnostic Substances) (2836) 581959440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1490733 Ken Ren Casi Pharmaceuticals, Inc.
9620 Medical Center Drive, Suite 300
Rockville MD 20850
Ceo And Director Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-01-19 7,537 $0.73 7,537 No 4 P Direct
Common Stock Acquisiton 2016-01-19 1,100 $0.74 8,637 No 4 P Direct
Common Stock Acquisiton 2016-01-19 6,063 $0.72 14,700 No 4 P Direct
Common Stock Acquisiton 2016-01-19 300 $0.71 15,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
No 4 P Direct